Addressing Escalating Medical Benefit Drug Pricing

1. Drugs have historically had price increases that exceed the consumer price index for pricing, although these increases have been tamed over the last several years, they continue to increase.

2. The ability to understand the characteristics tied to overall and drug level price increases provides organizations with an advantage in monitoring and implementing changes to ensure that costs are optimally managed.

3. Having the right tools to enable an organization to better manage drug pricing is a key component to implementing changes that optimize drug pricing.


Presented by:

Todd Cooperman, PharmD, MBA, RPh
Senior Vice President, Clinical Insight and Analytics
RJ Health


Join us on Thursday, August 23rd at 2:00 pm to Identify and Address the Escalating Medical Benefit Drug Pricing Issues.


Register Below Now: